Antipyretic TRIZ Cases

Cyclam bis-phosphorus ligands resolve slow complexation rates and low specific activity in copper radioisotope diagnostics.

Intranasal flunixin meglumine treats swine pain via nasal mucosa absorption, avoiding injection risks and improving worker safety.

Removing arginine from the formulation prevents oxidation while maintaining biological activity for twelve months across multiple concentrations.

Megamonas funiformis and Anaerofustis stercorihominis form a protective intestinal barrier to treat inflammation.

Administering metformin with sodium butyrate reduces tissue damage and promotes healing in radiation-induced injuries and periodontal disease.

Optimized buffer parameters reduce aggregation and degradation, extending shelf life under stress conditions.

Anti-CD38 antibodies stimulate cADPR hydrolase activity and inhibit NAADP formation.

Standardized ultrafiltration purifies lotus leaf-derived exosomes, resolving contradictions between extraction yield and particle stability.

Anti-FcRn antibodies bind human FcRn with high affinity to drive pathogenic IgG into lysosomes.

Bivalent antibodies bind human IL-17C homodimers, resolving mouse cross-reactivity issues by blocking receptor interaction.

A fixed-dose tablet merges pregabalin celecoxib and B vitamins into one immediate-release unit for chronic pain management.

Fluorescent caspase-1 inhibitors quantify cell barrier dysfunction through intensity changes, resolving diagnostic precision limits in IBS and IBD.

KDM5A inhibitors address sporadic inclusion body myositis by modulating epigenetic markers to restore muscle regeneration and halt disease progression.

Crystalline PN6047 hydrochloride forms HCl2 and HCl3 resolve solubility stability trade-offs via controlled phase transitions.

Formula I bicyclic dione compounds inhibit mutant KRAS activity to treat diseases associated with KRAS mutations.

Cyclic depsipeptides inhibit kallikrein 7 and human neutrophil elastase, restoring skin and lung barrier function in inflammatory diseases.

Fatty acid bile salt conjugates selectively modulate gut microbiota to restore homeostasis and alleviate disorders caused by dysbiosis.

Rose hip seed-enriched composition delivers enhanced antioxidant and anti-inflammatory effects through concentrated dried powdered seeds.

Engineered anti-CD37 antibodies overcome limited efficacy of CD20 therapies by improving B cell depletion and inducing apoptosis.

Clinoptilolite binds chemotherapeutic cytotoxic agents in the gut, preventing systemic absorption and reducing painful polyneuropathy symptoms.

Angiotensin 1-7 compounds activate the Mas receptor to reduce kidney damage and inflammation in systemic lupus erythematosus.

A hybrid molecule linking an Nrf2 activator with a carbonyl metal complex to simultaneously trigger cytoprotective pathways and release carbon monoxide.

Antibodies targeting PSGL-1 on activated T cells induce apoptosis to modulate immune responses.

A spring-loaded automatic injection device moves a syringe to project a needle for subcutaneous medication delivery.

Engineering the Fc region reduces ADCC activity while maintaining 70% NFkB inhibition, resolving toxicity risks in hematopoietic cells.

Composite hydrogels embed faster-degrading particles that dissolve into cavities, resolving low cell affinity and enabling tissue regeneration.

Engineered antibodies selectively bind human CD200R1 to inhibit innate immune responses without triggering cytokine release.

Leuconostoc bacteria-derived vesicles resolve chronic inflammation by inhibiting IL-6 secretion and suppressing tumor volume via mucosal barrier penetration.

Plinabulin inhibits PDE4 enzyme activity, reducing immunotherapy-related adverse events while maintaining anti-tumor efficacy.

Microneedle device with surface nanostructures penetrates the stratum corneum to facilitate drug transport across the dermal barrier.

Measuring CD3+, CD4+, CD8+, and HLA-II levels identifies responders before therapy, resolving the lack of predictive biomarkers for treatment optimization.

Specific point mutations in antibody variable regions optimize charge distribution, extending half-life while avoiding unintended CD40 agonist activity.

A pharmaceutical composition combining magnesium, ketoboswellic acid, and L-tryptophan delivers muscle relaxation and anti-inflammatory effects.

L-Arginine stabilizes antibody formulations to prevent aggregate formation and reduce viscosity without surfactants, enabling convenient subcutaneous injection.

Benzoxaborole compounds inhibit pro-inflammatory cytokines by modifying chemical structures to resolve treatment effectiveness limitations.

Antibodies targeting the hemopexin-like domain of MMP9 achieve specific inhibition without affecting other matrix metalloproteinases.

Hydrogel core with pH-dependent coating targets cyclosporin A to the colon, reducing systemic toxicity.

Monoacetyldiacylglycerol compounds inhibit STAT-3 phosphorylation, reducing inflammation and joint damage while avoiding the stomach toxicity of aspirin.

Segmenting monomers into asymmetric dimers via disulfide bonds achieves selective alpha4beta7 binding while avoiding harmful alpha4beta1 interference.

Merges three specific probiotic strains to alleviate inflammatory bowel disease symptoms by reducing inflammatory cell frequencies.

Hepatocyte growth factor induces peripheral mononuclear cells to differentiate into immunomodulatory leukocytes.

Specific CDR regions enable high-affinity binding to IL-33R, resolving incomplete Th2 suppression in chronic inflammatory conditions.

Antagonists block alpha v beta 5 integrin binding to reduce vascular permeability in sepsis treatment.

PLGA microparticles sustain SARM release to stabilize plasma levels and reduce injection frequency.

Novel anti-BAFF antibodies bind human BAFF with high affinity to neutralize multiple cytokine forms.

Human monoclonal antibodies bind B7RP1 to neutralize immune co-stimulatory activity, sparing naive T-cells and reducing side effects from broad inhibition.

A 99mTc-labeled RGD peptide tracer targets neoangiogenic vessels in inflamed joints for nuclear imaging.